Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

144 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Active, not recruiting

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

NCT04207944

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Active, not recruiting

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial

NCT05247905

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +11 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Epic Care-Dublin Dublin, California, United States
View all 171 locations
View Trial Details
Active, not recruiting

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

NCT02595424

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +19 more
Locations
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
View all 673 locations
View Trial Details
Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, not recruiting

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

NCT01824875

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +23 more
Locations
  • Kaiser Anaheim Medical Center Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente Medical Group - Baldwin Park Baldwin Park, California, United States
  • Kaiser Foundation Hospital Bellflower, California, United States
View all 323 locations
View Trial Details

Related conditions